Robert A. Mook
Impact in
- Molecular Biology top 10%
- RNA Interference and Gene Delivery
- Advanced biosensing and bioanalysis techniques
- Melanoma and MAPK Pathways
Papers in
-
- Wnt/β-catenin signaling in development and cancer 8
- Cancer-related gene regulation 5
- Melanoma and MAPK Pathways 3
- Hedgehog Signaling Pathway Studies 3
- Ubiquitin and proteasome pathways 3
-
- Quinazolinone synthesis and applications 2
- Co-authors
- Wei Chen (13 shared papers)Jiangbo Wang (11 shared papers)Richard T. Premont (3 shared papers)H. Kim Lyerly (9 shared papers)Xiu-Rong Ren (7 shared papers)Larry S. Barak (7 shared papers)W. Michael Flanagan (1 shared paper)John G. Lewis (1 shared paper)
- Journals
- Bioorganic & Medicinal Chemistry Letters (9 papers)Journal of Medicinal Chemistry (5 papers)Bioorganic & Medicinal Chemistry (4 papers)Molecular Cancer Therapeutics (2 papers)Scientific Reports (1 paper)
- Partner nations
- United StatesNetherlandsChina
In The Last Decade
Robert A. Mook
38 papers receiving 1.9k citations
Robert A. Mook's Hit Papers
Peers
Comparison fields: 5 of 114
- Molecular Biology 1.2k
- Anesthesiology and Pain Medicine 78
- Oncology 369
- Organic Chemistry 337
- Cell Biology 185
Countries citing papers authored by Robert A. Mook
This map shows the geographic impact of Robert A. Mook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Mook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Mook more than expected).
Fields of papers citing papers by Robert A. Mook
This network shows the impact of papers produced by Robert A. Mook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Mook. The network helps show where Robert A. Mook may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert A. Mook, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Niclosamide: Beyond an antihelminthic drug Hit paper breakdown → | 2017 | 337 |
| 2 | 1996 | 221 | |
| 3 | 2013 | 175 | |
| 4 | 2006 | 144 | |
| 5 | 2007 | 122 | |
| 6 | 2016 | 60 | |
| 7 | 2015 | 58 | |
| 8 | 2019 | 57 | |
| 9 | 2009 | 54 | |
| 10 | 1994 | 49 | |
| 11 | 1993 | 46 | |
| 12 | 2009 | 45 | |
| 13 | 2017 | 42 | |
| 14 | 2015 | 37 | |
| 15 | 2008 | 33 | |
| 16 | 2004 | 32 | |
| 17 | 2016 | 31 | |
| 18 | 1999 | 30 | |
| 19 | 1999 | 30 | |
| 20 | 1999 | 29 |
About Robert A. Mook
Robert A. Mook is a scholar working on Molecular Biology, Organic Chemistry, Cell Biology, Oncology and Pharmacology, having authored 38 papers that have together received 1.9k indexed citations. Recurring topics across this work include Wnt/β-catenin signaling in development and cancer (8 papers), Cancer-related gene regulation (5 papers), Microtubule and mitosis dynamics (4 papers), Melanoma and MAPK Pathways (3 papers), Hedgehog Signaling Pathway Studies (3 papers), Ubiquitin and proteasome pathways (3 papers), Quinazolinone synthesis and applications (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Molecular Biology (1.2k citations), Anesthesiology and Pain Medicine (78 citations), Oncology (369 citations), Organic Chemistry (337 citations) and Cell Biology (185 citations). Robert A. Mook has collaborated with scholars based in United States, Netherlands and China. Frequent co-authors include Wei Chen, Jiangbo Wang, Richard T. Premont, H. Kim Lyerly, Xiu-Rong Ren, Larry S. Barak, W. Michael Flanagan, John G. Lewis, Richard W. Wagner and Mark D. Matteucci. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry, Molecular Cancer Therapeutics and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.